United States Nuclear Regulatory Commission - Protecting People and the Environment

ACMUI Membership

The membership of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) includes health care professionals from various disciplines. The ACMUI is composed of the following: a nuclear medicine physician; a nuclear cardiologist; a medical physicist in nuclear medicine unsealed byproduct material; a medical physicist in radiation therapy; a radiation safety officer; a nuclear pharmacist; two radiation oncologists; a patients' rights advocate; a Food and Drug Administration representative; an Agreement State representative; a health care administrator; and a diagnostic radiologist.

Membership in the ACMUI is gained through a formal nomination and selection process. To fill vacancies on the ACMUI, the U.S. Nuclear Regulatory Commission (NRC) publishes a notice in the Federal Register requesting nominations from interested parties. After receiving nominations, the NRC convenes a selection panel consisting of NRC staff and a non-NRC Federal employee. This non-NRC Federal employee is always a professional who specializes in the vacancy to be filled. The selection panel evaluates each nominee and sends a recommendation for appointment by the Director, Office of Nuclear Material Safety and Safeguards. The Director reviews the recommendation, consults with the Commission, and appoints the ACMUI member.

ACMUI members are appointed to four-year terms and, with approval from NRC, may elect to serve up to two consecutive terms, for a maximum term of eight years.

Members pictured from left to right, top to bottom:  Dr. Vasken Dilsizian, Mr. Richard Green, Dr. Michael O'Hara, Dr. Ronald Ennis, Dr. John Suh, Ms. Megan Shober, Ms. Laura Weil, Dr. Pat Zanzonico, Dr. Philip Alderson, Dr. Christopher Palestro, Mr. Zoubir Ouhib, and Dr. Darlene Metter.
Members pictured from left to right, top to bottom: Dr. Vasken Dilsizian, Mr. Richard Green, Dr. Michael O'Hara, Dr. Ronald Ennis, Dr. John Suh, Ms. Megan Shober, Ms. Laura Weil, Dr. Pat Zanzonico, Dr. Philip Alderson, Dr. Christopher Palestro, Mr. Zoubir Ouhib, and Dr. Darlene Metter.


For additional information on ACMUI membership see the list of ACMUI Specialties and Functions and NUREG/BR-0309, "Serving on the Advisory Committee on the Medical Uses of Isotopes (ACMUI): A Member's Guide."

Select one of the following names for biographical information.

Chairman: Christopher J. Palestro, M.D., Nuclear Medicine Physician
Vice Chairman: Darlene F. Metter, M.D., Diagnostic Radiologist

Members:
Vasken Dilsizian, M.D., Nuclear Cardiologist
Ronald D. Ennis, M.D., Radiation Oncologist
Richard L. Green, Nuclear Pharmacist
Darlene F. Metter, M.D., Diagnostic Radiologist
Michael D. O'Hara, Ph.D., Food and Drug Administration Representative
Zoubir Ouhib, Therapy Medical Physicist
Christopher J. Palestro, M.D., Nuclear Medicine Physician
Michael Sheetz, Radiation Safety Officer
Megan L. Shober, Agreement State Representative
John H. Suh, M.D., Radiation Oncologist
Laura M. Weil, Patients' Rights Advocate
Pat B. Zanzonico, Ph.D., Medical Physicist, Nuclear Medicine

See Previous ACMUI members

To top of page

Philip O. Alderson, M.D.

photo of Philip O. Alderson, M.D., Health Care Administrator

Philip O. Alderson, M.D., serves as the Healthcare Administrator representative on the ACMUI. Dr. Alderson was appointed to the ACMUI in March 2014, was appointed Vice Chair of the ACMUI in January 2015, and was appointed Chair of the ACMUI in October 2015.

Dr. Alderson earned his bachelor's and medical degrees from Washington University in St. Louis. He is board certified by the American Board of Nuclear Medicine and the American Board of Radiology (Diagnostic).

In April 2008 Dr. Alderson was appointed Dean, Saint Louis University School of Medicine. As Dean of the School of Medicine, Dr. Alderson oversees the education, research and clinical service missions of the School. Since February 2009 Dr. Alderson also has served as a Vice President at Saint Louis University (Health Sciences 2009-11, Medical Affairs 2011-present). Prior to these appointments, Dr. Alderson was a faculty member at the Johns Hopkins Medical Institutes from 1975-80 and a professor of radiology at the College of Physicians and Surgeons of Columbia University from 1980-2008 where he served as chair of the Department of Radiology (1988-2008) and as President of the Medical Board at New York Presbyterian (2004-06).

Dr. Alderson has served as President of the American Board of Radiology and the American Roentgen Ray Society, as well as other medical organizations. He was a member of the National Advisory Council of the NIH (2008-2012). He is currently a member of the NIH Council of Councils (2013-2016). Dr. Alderson has over 200 publications, including 4 books, 40 book chapters and over 150 journal articles. He has made more than 200 presentations at local, national and international meetings and scientific symposia and is listed in "Who's Who in the World," "Who's Who in America," "Who's Who in Medicine and Healthcare," among others.

To top of page

Vasken Dilsizian, M.D.

photo of Vasken Dilsizian, M.D., Nuclear Cardiologist

Vasken Dilsizian, M.D., FACC, FAHA, serves as the nuclear cardiologist representative on the ACMUI. Dr. Dilsizian was appointed to the ACMUI in May 2014.

Dr. Dilsizian earned a Bachelor of Science and Master of Science Degrees in Chemical Engineering from Tufts University in Medford, Massachusetts, and a Medical Degree from Tufts University School of Medicine, in Boston, Massachusetts. Dr. Dilsizian is board certified by the American Board of Internal Medicine, the American Board of Cardiovascular Medicine, and the American Board of Nuclear Medicine.

Dr. Dilsizian was appointed as professor of radiology and medicine at the University of Maryland School of Medicine in 2001, and the Director of Cardiovascular Nuclear Medicine and Cardiac PET within the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland Medical Center. Dr. Dilsizian was appointed as the Chief of the Nuclear Medicine Division within the Department of Diagnostic Radiology University of Maryland School of Medicine in 2007. Prior to this appointment, Dr. Dilsizian served as the Director of Nuclear Cardiology at the National Institutes of Health (NIH) from 1992-2001.

Dr. Dilsizian is active and serves (and has served) in leadership roles in various professional organizations including the American Society of Nuclear Cardiology (ASNC), the Society for Nuclear Medicine and Molecular Imaging (SNMMI), the American College of Cardiology (ACC), and the American Heart Association (AHA). He is a founding member of ASNC and served as the Chair for the ASNC 2014 Scientific Program Committee. He served as the President of the Cardiovascular Council of the SNMMI (2013-2014) and was awarded the 2014 Hermann Blumgart Award for his innumerable contributions to the science of nuclear cardiology. In 2016, he was bestowed as "Master" of American Society of Nuclear Cardiology (MASNC) for his contribution to the field of nuclear cardiology and for holding senior leadership positions within the Society. Dr. Dilsizian was elected as the incoming Vice President Elect of the SNMMI in June of 2017, which will lead to the Presidency of the Society in 2 years (2019-2020). He was also selected to serve as a member of the Board of Scientific Counselors of the Clinical Center of the National Institutes of Health for four-years (2018-2022). Dr. Dilsizian also has experience serving on an FDA Federal Advisory Committee (Cardiovascular and Renal Drugs Advisory Committee). Dr. Dilsizian has over 208 original, peer-reviewed manuscripts and invited editorials/articles, 10 books, and 43 book chapters.

To top of page

Ronald D. Ennis, M.D.

photo of Ronald D. Ennis, M.D., Radiation Oncologist

Ronald D. Ennis, M.D., serves as the brachytherapy radiation oncologist representative on the ACMUI. Dr. Ennis was appointed in March 2015.

Dr. Ennis received his Bachelor of Arts from Columbia University in New York, NY and his Medical Degree from Yale University School of Medicine in New Haven, CT. Dr. Ennis was board certified in radiation oncology by the American Board of Radiology (ABR) in 1995. He served as the Director for the Department of Radiation Oncology at St. Luke's Roosevelt Hospital Center and as Associate Director for the Continuum Cancer Centers of New York, Continuum Health Partners, both in New York, New NY, for eight years (2005-2013) prior to joining the faculty at the Icahn School of Medicine at Mount Sinai in New York, NY in 2014. Dr. Ennis was appointed as the Director for the Department of Radiation Oncology at Mount Sinai Roosevelt Hospital in New York, NY in January 2014 where he also serves as Chairman of the Quality Assurance and Safety Committee for the Radiation Oncology department.

Dr. Ennis is active in various professional organizations including the American Society for Therapeutic Radiology and Oncology (ASTRO), the Roentgen Society, and the American Board of Radiology (ABR). He currently serves as the Vice Chairman of ASTRO's Government Relations Committee, Government Relations Council. He is a member of the Editorial Board and Manuscript Reviewer of the Journal of Clinical Oncology and Manuscript Reviewer of Urology; Brachytherapy; and Cancer. Dr. Ennis has over 40 peer-reviewed publications and over 80 abstracts, meeting proceedings, letters, invited chapters and thesis publications.

Dr. Ennis is also actively involved in research on methods for treating prostate cancer by treating just the tumor versus the whole gland.

To top of page

Richard L. Green

Richard L. Green

Richard L. Green has been selected as the Nuclear Pharmacist representative on the ACMUI.

Mr. Green holds a Bachelor's degree in Pharmacy from the University of Arizona in Tucson, Arizona and has been an Authorized Nuclear Pharmacist since 1988. In 1992, Mr. Green received his board certification in nuclear pharmacy by the Board of Pharmacy Specialties (BPS). He was appointed to the position of Director of Radiopharmacy Practice at Cardinal Health Nuclear Pharmacy Services (hereafter referred to as Cardinal Health) in 2006. Prior to that, Mr. Green served as the Program Manager and Senior Manager of Pharmacy Practice at Cardinal Health in Dublin Ohio, as the Pharmacy Manager and Radiation Safety Officer at Syncor International Corporation in Las Vegas, Nevada and as a Staff Pharmacist and Radiation Safety Officer for Syncor International Corporation in Phoenix, Arizona. Mr. Green has taught radiopharmacy to pharmacists as part of several university affiliated ANP certificate programs for the past 27 years.

Mr. Green has served on the BPS Nuclear Pharmacy Specialty Council as a specialist member and as elected Chair. Mr. Green was named a Fellow of the American Pharmacist Association in 2018. In addition, he is an active member of the Society of Nuclear Medicine and Molecular Imaging, the American Pharmacist Association and the American Society of Health System Pharmacists. Lastly, Mr. Green has made numerous presentations, has had articles accepted for publication as well as five patents.

To top of page

Darlene F. Metter, M.D.

Darlene F. Metter, M.D.

Darlene F. Metter, M.D., serves as the Diagnostic Radiologist representative on the ACMUI.  Dr. Metter was appointed to the ACMUI in June 2016 and Vice Chair of the ACMUI in March 2018.

Dr. Metter holds a Bachelor's degree from University of Hawaii in Honolulu, Hawaii and a Medical Degree from John A. Burns School of Medicine at the University of Hawaii in Honolulu, Hawaii.  Dr. Metter received triple board certifications in family medicine by the American Board of Family Medicine (1981), in diagnostic radiology by the American Board of Radiology (1992), and in nuclear medicine by the American Board of Nuclear Medicine (1993). 

Dr. Metter currently serves as a professor of diagnostic radiology and family and community medicine at the University of Texas Health Science Center in San Antonio, Texas and as the site director for the nuclear medicine residency program for the San Antonio Uniformed Services Health Education Consortium.  She was appointed to the position of adjunct professor and cross-appointed faculty at the University of Texas Health Science Center (UTHSCSA) in 2011 and as professor in the Department of Radiology at UTHSCHSA in 2009.  Prior to that, Dr. Metter served as staff radiologist at CHRISTUS Santa Rosa Hospital Medical Center and Metropolitan Hospital.  She also served as clinic radiologist at the Alamo Diagnostic Imaging Center, Advanced Medical Imaging, at North San Pedro Imaging.

Dr. Metter holds a gubernatorial appointment to the Texas Radiation Advisory Board (TRAB) and serves and has served, in leadership positions for numerous professional organizations.  These organizations include the following:  the American Board of Radiology (Chair of the Certifying and Maintenance of Certification Exam for Nuclear Radiology), the American College of Radiology (ACR) (current member of the ACR Council Steering Committee and was named ACR Fellow in 2007), the Society of Nuclear Medicine and Molecular Imaging (SNMMI)(President of the Academic Council, past President of the Southwest Chapter of SNMMI, and past Chair of the Nuclear Medicine Program Directors), and the Accreditation Council for Graduate Medical Education (ACGME) (Chair of the Nuclear Medicine Residency Review Committee and Vice-Chair of ACGME Council of Review Committees).

To top of page

Michael D. O'Hara, Ph.D.

Photo Not Available placeholder image

Michael D. O'Hara, Ph.D., has served as the Food and Drug Administration (FDA) representative on the ACMUI since November 2014.

Dr. O'Hara earned his bachelor's degree in biology from D'Youville College in Buffalo, a master's degree in Natural Sciences from the State University of New York at Buffalo and a doctorate of philosphy in Biological Sciences from Wayne State University in Detroit. He completed a postdoctoral fellowship in the laboratory of Experimental Radiation Oncology at Thomas Jefferson University in Philadelphia.

He remained as a faculty member at Thomas Jefferson University Medical College in the Department of Radiation Oncology. He lead research efforts investigating the impact of chemical agents that modify the thermal response of normal and malignant tissues during thermal/radiotherapy and investigated bone marrow transplantation as a method to treat osteogenesis imperfecta. Dr. O'Hara regularly taught an undergraduate course in "Health Physics and Radiation Biology", lectured medical residents and was a member of the Institutional Animal Care and Use Committee.

Dr. O'Hara moved to Cordis / a Johnson and Johnson company to manage the firm's radiation therapy efforts involving radioactive endovascular stents and catheter-based radiation sources. He was promoted to a Johnson and Johnson Research Fellow and continued to assist Cordis and other Johnson and Johnson companies with radiation-based therapies.

He joined the Food and Drug Administration in 2004 in the Division of Biology in the Office of Science and Engineering Laboratories within the Center for Devices and Radiological Health. His activities included research studies involving Relative Biological effectiveness of ionizing radiation and the thermal / radiotherapeutic response of human tumor cells. He also served as the chairman of the Animal Care and Use Committee and has served as a member of the CDRH Radiology Standards Committee, the CDRH Radiofrequency Working Group, the Interagency Radiofrequency Working group and the Health and Human Services Radiation Biodosimetry Working Group. Dr. O'Hara served the Office of Device Evaluation and the Office of In Vitro Diagnostics as an Acting Branch Chief and later an Acting Deputy Division Director. He currently serves the Office of In Vitro Diagnostics and Radiological health as one of the Deputy Division Directors of the Division of Radiological Health. This division is responsible for the pre-market evaluation, post-market medical device reporting and compliance for all radiation emitting medical devices.

To top of page

Zoubir Ouhib

Zoubir Ouhib

Zoubir Ouhib serves as the Therapy Medical Physicist representative on the ACMUI. Mr. Ouhib was appointed to the ACMUI in April 2018.

Mr. Ouhib holds a Master's degree in Medical Physics from the University of Cincinnati in Cincinnati, Ohio and another Master's degree in Nuclear Engineering from Georgia Institute of Technology in Atlanta, Georgia. Mr. Ouhib received his board certification in radiation therapy by the American Board of Radiology in 1992.

Mr. Ouhib was appointed to his current position as Chief Medical Physicist at the Lynn Cancer Institute of the Boca Raton Community Hospital in 1998. Prior to that, Mr. Ouhib served as Director of Medical Physics at Elliot Hospital in Manchester, New Hampshire and as Medical Physicist at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

Mr. Ouhib serves and has served, in numerous leadership positions. These organizations include the following: the American Association of Physicists in Medicine (AAPM) (Vice Chair of the AAPM Task Groups BTSC, TG244, TG-236, TG182, TG253 and Working Group on Brachytherapy), the American Brachytherapy Society (ABS) (Past Chair of the ABS Physics Committee, Chair of the ABS Patient Safety Committee, Chair of the ABS Quality of Management of Brachytherapy School, and Chair of the ABS Dosimetry and Clinical Practice Aspects of Skin Brachytherapy Working Group), the American College of Radiology, the American Society of Therapeutic Radiology and Oncology (ASTRO), and the European Society for Radiology and Oncology.

To top of page

Christopher J. Palestro, M.D.

photo of Christopher J. Palestro, M.D.

Christopher J. Palestro, M.D. serves as the nuclear medicine physician representative on the ACMUI. Dr. Palestro was appointed in to the ACMUI in September 2011 and as Chair of the ACMUI in March 2018.

Dr. Palestro received a B.S. in Biology from Fordham University, Bronx, NY, and his M.D. from the Universidad Autonoma de Guadalajara, Guadalajara Mexico. He completed a residency in Diagnostic Radiology at the Roosevelt Hospital in New York City, followed by a residency in Nuclear Medicine at Memorial Sloan Kettering Cancer Center, also in New York City. He was certified by the American Board of Nuclear Medicine in 1982.

From 1982-1985, Dr. Palestro was the Chief of the Section of Nuclear Medicine at Norwalk Hospital in Norwalk, CT. From 1985-1992, he was an attending physician and assistant clinical director in the Andre-Meyer Department of Physics-Nuclear Medicine of Mount Sinai Medical Center in New York City. He was appointed an Assistant Professor of Radiology in the Mt. Sinai School of Medicine in 1985, and was promoted to Associate Professor in 1990. In 1992 Dr. Palestro was appointed Chief of the Division of Nuclear Medicine of Long Island Jewish Medical Center in New Hyde Park, NY. In the same year he was appointed an Associate Professor of Nuclear Medicine and Radiology at the Albert Einstein College of Medicine of Yeshiva University (Bronx, NY), and was promoted to Professor in 1996.

In 2007 Dr. Palestro was appointed chief of the Division of Nuclear Medicine and Molecular Imaging of the North Shore Long Island Jewish Health System, a position he currently holds. He has been a professor of Radiology at the Hofstra University School of Medicine in partnership with North Shore Long Island Jewish Health System since 2009.

An internationally recognized authority on nuclear medicine imaging of infection, Dr. Palestro has authored or coauthored more than 125 peer reviewed articles, and more than 50 book chapters and review articles. He has served as a reviewer for the Journal of Nuclear Medicine, European Journal of Nuclear Medicine & Molecular Imaging, Radiology, and the New England Journal of Medicine, among others. Dr. Palestro has been an associate editor of the Journal of Nuclear Medicine, and currently serves on the editorial boards of Radiology and the Quarterly Journal of Nuclear Medicine and Molecular Imaging. A life member and past chair of the American Board of Nuclear Medicine, Dr. Palestro currently is chair of the Accredited Council for Graduate Medical Education (ACGME) Nuclear Medicine Residency Review Committee. He is a past president of The International Society of Radiolabeled Blood Elements, an organization dedicated to the investigation of nuclear medicine techniques for imaging inflammation and infection. He is chair of the Infection Section of the Society of Nuclear Medicine Procedure Guidelines Task Force, and Vice-chair of the Hematopoietic and Musculoskeletal Sections of that society's Lifelong Learning Self-Assessment Programs. Dr. Palestro has received awards for "Reviewing with Distinction" and "Reviewing with Special Distinction," from the journal Radiology and in 2003 was the recipient of Greater New York Chapter of the Society of Nuclear Medicine "Berson-Yalow Award." He frequently has been selected as one of the "Best Doctors in New York" and as one of the "Best Doctors in America."

To top of page

Michael A. Sheetz

Photo Not Available placeholder image

Michael A. Sheetz, serves as the Radiation Safety Officer representative on the ACMUI. Mr. Sheetz was appointed to the ACMUI in September 2017.

Mr. Sheetz holds a Bachelor's degree in Biological Sciences/Health Planning and Administration from Pennsylvania State University and a Master's degree in Radiation Health from the University of Pittsburgh's Graduate School of Public Health. Mr. Sheetz received his board certification in comprehensive health physics from the American Board of Health Physics in 1988. And his board certification in medical health physics from the American Board of Medical Physics (ABMP) in 2003.

He was appointed to his current position of Director of the Radiation Safety Office and as Radiation Safety Officer at the University of Pittsburgh in 2007. Prior to this appointment, Mr. Sheetz served as a Health Physicist in the Radiation Safety Office at the University of Pittsburgh from 1982-2007.

Mr. Sheetz has served in leadership roles in various professional organizations including the Health Physics Society (HPS), the American Association of Physicists in Medicine (AAPM), the American Academy of Health Physics, ABMP, and the Society of Nuclear Medicine and Molecular Imaging. He served as President for the HPS Western Pennsylvania Chapter and currently sits on the board of directors for ABMP. He is also a member of several committees including the Pennsylvania Radiation Protection Advisory Committee, the Pennsylvania Low Level Waste Advisory Committee, AAPM's Government and Regulatory Affairs Committee, and HPS's Government Relations Committee.

To top of page

Megan L. Shober

Megan L. Shober

Megan L. Shober serves as the Agreement State Representative on the ACMUI. Ms. Shober was appointed to the ACMUI in April 2018.

Ms. Shober holds a Bachelor's degree in Geology from the College of Wooster, in Ohio, and a Master's degree in Geophysics from the University of Wisconsin-Madison.

Since 2003, Ms. Shober has been a Nuclear Engineer for the Wisconsin Division of Public Health in Madison, Wisconsin, where she is responsible for licensing and inspecting radioactive materials licensees and participating in emergency response activities. Ms. Shober has been the lead investigator for medical events involving manual brachytherapy, High Dose Rate remote afterloaders, leaking sources and iodine-131 fetal exposure. In addition, Ms. Shober is a regulatory expert on licensing domestic supplies of molybdenum-99.

Ms. Shober is active in various professional organizations including the Conference for Radiation Control Program Directors and the Organization of Agreement States (OAS), where she served on the Executive Board from 2013-2016. From 2012-2014, Ms. Shober served as a co-chair of the NRC-OAS 10 CFR 35.1000 working group for the ViewRay™ System for Radiation Therapy. Ms. Shober has given conference presentations on the ViewRay™ System for Radiation Therapy, 10 CFR Part 37, and licensing alpha-emitting radiopharmaceuticals.

To top of page

John H. Suh, M.D.

John H. Suh

John H. Suh, M.D., serves as one of the radiation oncologist representatives on the ACMUI. Dr. Suh was appointed in October 2010.

Dr. Suh received his bachelor's and medical degree from the University of Miami's Honors Program in Medical Education. He then completed his residency and fellowship in radiation oncology at the Cleveland Clinic.

Following his residency, he joined the faculty at the Cleveland Clinic in 1995 where he specialized in neuro-oncology and stereotactic radiosurgery. From 1996 to 2002, he was the residency director. In 1999, he became clinical director for the department. In 2003, he became the Director of the Cleveland Clinic Gamma Knife Center. Since 2006, he has served as Chair of the Department of Radiation Oncology at the Cleveland Clinic Taussig Cancer Institute. He is also Associate Director of the Gamma Knife Center and the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. He is board certified in radiation oncology and currently serves as the section head for the Central Nervous System/pediatric section for the American Board of Radiology's oral board examination.

His awards have included the National Brain Tumor Foundation Clinical Research Award, Teacher of the Year Award, and selection as one of America's Top Physicians for Cancer. He was the principal investigator for two phase III trials testing a radiation sensitizer with whole brain radiation therapy for patients with brain metastases.

His patient care, research and teaching interests include adult and pediatric brain tumors, Gamma Knife radiosurgery, and innovative radiation approaches. He has authored over 120 publications and has served as the institutional principal investigator for the Radiation Therapy Oncology Group at the Cleveland Clinic since 1995. Dr. Suh has lectured extensively locally, nationally and internationally. He serves as a reviewer for a number of medical journals and is a member of many professional societies.

To top of page

Laura M. Weil

Photo of Laura M. Weil, Patients' Rights Advocate

Laura M. Weil serves as the patients' rights advocate on the ACMUI. Ms. Weil was appointed in August 2011.

Ms. Weil earned her Bachelors of Arts degree from SUNY Albany. She obtained a Masters degree from Sarah Lawrence College's graduate program in Health Advocacy. Her area of advocacy specialization centers on the rights of human subjects in clinical trial research.

She is Director Emeritus of Sarah Lawrence College's master's degree program in Health Advocacy, where she served on the college's graduate faculty for 13 years. Additionally, she taught courses in clinical ethics at Touro College Health Sciences Program.

She serves on Mount Sinai Beth Israel Medical Center's Institutional Review Board, where she is a reviewer of proposed clinical trials with respect to patients' rights. She has served as a consultant to the National Institute of Mental Health, reviewing human subjects research applications for federal funding. Her career includes positions as a patient advocate at several medical centers in New York City, including nine years as the director of patient advocacy at Beth Israel Medical Centers.

Ms. Weil served as president of New York State Society of Patient Representatives and was a board member of the National Society for Healthcare Consumer Advocacy of the American Hospital Association. She was a founding member on the Executive Committee of the National Association of Healthcare Advocacy Consultants and a member of the Metropolitan New York Ethics Network.

To top of page

Page Last Reviewed/Updated Tuesday, May 29, 2018